Therapeutic gene products delivery by neuron stem cells

Current Pharmaceutical Biotechnology

Volumn 13, Issue 12, 2012, Pages 2427-2431

  Tan, Jie ^a   Meng, Yanna ^a   Huang, Shiang ^a   Wang, Ping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Antibody neural disorder; Gene therapy; Malignant tumors; Stem progenitor cells

Indexed keywords

ANTIGEN; CD17 ANTIGEN; CD2 ANTIGEN; CYTOKINE; INTERLEUKIN 12; INTERLEUKIN 4; INTERLEUKIN 4.3; NERVE GROWTH FACTOR; TRASTUZUMAB; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; UNCLASSIFIED DRUG; VASCULOTROPIN;

ALZHEIMER DISEASE; BRAIN METASTASIS; BREAST CANCER; BREAST CARCINOMA; CARCINOGENICITY; CARDIOMYOPATHY; CELL INFILTRATION; CEREBROVASCULAR ACCIDENT; CONGESTIVE HEART FAILURE; FACIAL NERVE DISEASE; GENE TARGETING; GLIOMA; HUMAN; HUNTINGTON CHOREA; IMMUNOGENICITY; LUNG TOXICITY; MEDULLOBLASTOMA; NEURAL STEM CELL; NEUROBLASTOMA; NONHUMAN; PARKINSON DISEASE; RETT SYNDROME; REVIEW; SPINAL CORD INJURY; TROPISM;

ALZHEIMER DISEASE; ANIMALS; BRAIN NEOPLASMS; BREAST NEOPLASMS; FEMALE; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; GLIOMA; HUMANS; NEURAL STEM CELLS; SPINAL CORD INJURIES;

EID: 84867711791     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920112803341806     Document Type: Review

References (69)

1. Aboody K.S.; Brown A.; Rainov N. G; Bower K. A; Liu S.; Yang W.; Small J;E.; Herrlinger U.; Ourednik V.; Black P.M.; Breakefield X.O.; Snyder E.Y. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Sci. USA., 2000 Nov. 7; 97(23), 12846-12851.
2. Adams G.P.; Schier R.; McCall A.M.; Simmons H.H.; Horak E.M.; Alpaugh R.K.; Marks J.D.; Weiner L.M. High affinity restricts the localization and tumor penetration of single-chain fv antibody molecules. Cancer Res., 2001 June. 15, 61(12), 4750-4755.
3. Snyder E.Y. Neural stem-like cells:developmental lessons with therapeutic potential. Neuroscientist, 1998; 4, 408-425.
4. Sun L.; Lee J.; Fine H.A. Neuronally expressed stem cell factor induces neural stem cell migration to areas of brain injury. J. Clin. Invest., 2004, 113, 1364-74.
5. Ehtesham M.; Yuan X.; Kabos P.; et al. Glioma tropic neural stem cells consist of astrocytic precursors and their migratory capacity is mediated by CXCR4. Neoplasia, 2004, 6, 287-93.
6. Schmidt N.O.; Przylecki W.; Yang. W.; et al. Brain tumor tropism of transplanted human neural stem cells is in-duced by vascular endothelial growth factor. Neoplasia, 2005, 7, 623-629.
7. De Wever O.; Mareel M. Role of tissue stroma in cancer cell invasion. J. Pathol., 2003, 429-447.
8. Michotte A.; Neyns B.; Chaskis C.; Sadones J. In 't Veld P. Neuropathological and molecular aspects of low-grade and high-grade gliomas. Acta. Neurol. Belg., 2004, 104, 148-53.
9. Jensen R.L. Hypoxia in the tumorigenesis of gliomas and as a potential target for therapeutic measures. Neurosurg. Focus, 2006, 20, E24.
10. Aboody K.S.; Najbauer J.; Danks M.K. Stem and progenitor cellmediated tumor selective gene therapy. Gene Ther., 2008 May, 15(10), 739-752.
11. Aboody K.S.; Najbauer J.; Schmidt N.O.; Yang W.; Wu J.K.; Zhuge Y.; Przylecki W.; Carroll R.; Black P.M.; Perides G. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro. Oncol., 2006 April, 8(2), 119-26. Epub. 2006 Mar 8.
12. Zhao D.; Najbauer J.; Garcia E.; Metz M.Z.; Gutova M.; Glackin C.A.; Kim S.U.; Aboody K.S. Neural stem cell tropism to glioma: critical role of tumor hypoxia. Mol. Cancer Res.,. 2008, Dec., 6(12), 1819-29.
13. Aboody K.S.; Bush R.A.; Garcia E.; Metz M.Z.; Najbauer J.; Justus K.A.; Phelps D.A.; Remack J.S.; Yoon K.J.; Gillespie S.; Kim S.U.; Glackin C.A.; Potter P.M.; Danks M.K. Development of a tumor-selective approach to treat metastatic cancer. PLoS One. 2006, Dec., 20;1:e23.
14. Brown A.B.; Yang W.; Schmidt N.O.; Carroll R.; Leishear K.K.; Rainov N.G., Black P.M.; Breakefield X.O.; Aboody K.S. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum. Gene Ther., 2003, Dec. 10; 14(18), 1777-1785.
15. Danks M.K.; Yoon K.J.; Bush R.A.; Remack J.S.; Wierdl M.; Tsurkan L.; Kim S.U.; Garcia E.; Metz M.Z.; Najbauer J.; Potter P.M.; Aboody K.S. Tumortargeted enzyme/prodrug therapy mediates long-term disease-free survival of mice bearing disseminated neuroblastoma. Cancer Res., 2007 Jan. 1; 67(1), 22-25.
16. Kim S.U.; Nakagawa E.; Hatori K.; Nagai A.; Lee M.A.; Bang J.H. Production of immortalized human neural crest stem cells. Methods Mol. Biol., 2002, 198, 55-65.
17. Joo K.M.; Park I.H.; Shin J.Y.; Jin J.; Kang B.G.; Kim M.H.; Lee S.J.; Jo M.Y.; Kim S.U.; Nam D.H. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases. Mol. Ther., 2009 Mar;17(3), 570-575, Epub. 2009 Jan. 6.
18. Palmieri D.; Bronder J.L.; Herring J.M.; Yoneda T.; Weil R.J.; Stark A.M.; Kurek R.; Vega-Valle E.; Feigenbaum L.; Halverson D.; Vortmeyer A.O.; Steinberg S.M.; Aldape K.; Steeg P.S. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain. Cancer Res., 2007 May 1; 67(9), 4190-4198.
19. Molina M.A.; Codony-Servat J.; Albanell J.; Rojo F.; Arribas J.; Baselga J. Trastuzumab (herceptin), a humanized anti-Her2 receptor monoclonal antibody, inhibits basal and activated Her2 ectodomain cleavage in breast cancer cells. Cancer Res., 2001, Jun 15; 61(12), 4744-4749.
20. Kute T.; Lack C.M.; Willingham M.; Bishwokama B.; Williams H.; Barrett K.; Mitchell T.; Vaughn J.P. Development of Herceptin resistance in breast cancer cells. Cytometry A. 2004, Feb; 57(2), 86-93.
21. Nahta R.; Yuan L.X.; Zhang B.; Kobayashi R.; Esteva F.J. Insulinlike growth factor-I receptor/human epidermal growth factor receptor 2 heterodimerization contributes to trastuzumab resistance of breast cancer cells. Cancer Res., 2005, Dec 1; 65(23), 11118-11128.
22. Dimopoulou I, Bamias A, Lyberopoulos P, Dimopoulos MA. Pulmonary toxicity from novel antineoplastic agents. Ann. Oncol., 2006, Mar; 17(3), 372-379, Epub 2005 Nov. 16.
23. Negro A.; Brar B.K.; Lee K.F. Essential roles of Her2/erbB2 in cardiac development and function. Recent Prog. Horm. Res., 2004; 59, 1-12.
24. Frank R.T.; Edmiston M.; Kendall S.E.; Najbauer J.; Cheung C.W.; Kassa T.; Metz M.Z.; Kim S.U.; Glackin C.A.; Wu A.M.; Yazaki P.J.; Aboody K.S. Neural stem cells as a novel platform for tumorspecific delivery of therapeutic antibodies. PLoS One. 2009 Dec. 15, 4(12): e831.
25. Schwab J.M.; Brechtel K.; Mueller C.A.; Failli V.; Kaps H.P.; Tuli S.K.; Schluesener H.J. Experimental strategies to promote spinal cord regeneration-an integrative perspective. Prog. Neurobiol., 2006, Feb; 78(2), 91-116. Epub 2006 Feb 17.
26. Blesch A.; Lu P.; Tuszynski M.H. Neurotrophic factors, gene therapy, and neural stem cells for spinal cord repair. Brain Res. Bull. 2002, Apr; 57(6), 833-838.
27. Rosenstein J.M.; Krum J.M. New roles for VEGF in nervous tissuebeyond blood vessels. Exp. Neurol., 2004, Jun; 187(2), 246-253.
28. Jin K.L.; Mao X.O.; Greenberg D.A. Vascular endothelial growth factor: direct neuroprotective effect in in vitro ischemia. Proc. Natl. Acad. Sci. USA., 2000, Aug 29, 97(18), 10242-10247.
29. Matsuzaki H.; Tamatani M.; Yamaguchi A.; Namikawa K.; Kiyama H.; Vitek M.P.; Mitsuda N.; Tohyama M. Vascular endothelial growth factor rescues hippocampal neurons fromglutamateinduced toxicity: signal transduction cascades. FASEB J., 2001, May; 15(7), 1218-1220.
30. Khaibullina A.A.; Rosenstein J.M.; Krum J.M. Vascular endothelial growth factor promotes neurite maturation in primary CNS neuronal cultures. Brain Res. Dev. Brain Res., 2004, Jan 31; 148(1), 59-68.
31. Mani N.; Khaibullina A.; Krum J.M.; Rosenstein J.M. Astrocyte growth effects of vascular endothelial growth factor (VEGF) application to perinatal neocortical explants: receptor mediation and signal transduction pathways. Exp. Neurol., 2005, Apr; 192(2), 394-406.
32. Sondell M.; Lundborg G.; Kanje M. Vascular endothelial growth factor has neurotrophic activity and stimulates axonal outgrowth, enhancing cell survival and Schwann cell proliferation in the peripheral nervous system. J. Neurosci., 1999, Jul 15; 19(14), 5731-5740.
33. Widenfalk J.; Lipson A.; Jubran M.; Hofstetter C.; Ebendal T.; Cao Y.; Olson L. Vascular endothelial growth factor improves functional outcome and decreases secondary degeneration in experimental spinal cord contusion injury. Neuroscience. 2003, 120(4), 951-60.
34. Storkebaum E.; Lambrechts D.; Dewerchin M.; Moreno-Murciano M.P.; Appelmans S.; Oh H.; Van Damme P.; Rutten B.; Man W.Y.; De Mol M.; Wyns S.; Manka D.; Vermeulen K.; Van Den Bosch L.; Mertens N.; Schmitz C.; Robberecht W.; Conway E.M.; Collen D.; Moons L.; Carmeliet P. Treatment of motoneuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat. Neurosci., 2005, Jan; 8(1), 85-92. Epub 2004 Nov 28.
35. Sun Y.; Jin K.; Xie L.; Childs J.; Mao X.O.; Logvinova A.; Greenberg D.A. VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J. Clin. Invest., 2003, Jun; 111(12), 1843-1851.
36. Weiss S.; Dunne C.; Hewson J.; Wohl C.; Wheatley M.; Peterson A.C.; Reynolds B.A. Multipotent CNS stem cells are present in the adult mammalian spinal cord and ventricular neuroaxis. J. Neurosci., 1996, Dec, 1; 16(23), 7599-7609.
37. McTigue D.M.; Wei P.; Stokes B.T. Proliferation of NG2-positive cells and altered oligodendrocyte numbers in the contused rat spinal cord. J. Neurosci., 2001, May 15; 21(10), 3392-400.
38. Zai L. J,; Wrathall J.R. Cell proliferation and replacement following contusive spinal cord injury. Glia, 2005, May; 50(3), 247-257.
39. Tripathi R.; McTigue D.M. (2007) Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia, 55, 698-711.
40. Yang H.; Lu P.; McKay H.M.; Bernot T.; Keirstead H.; Steward O.; Gage F.H.; Edgerton V.R.; Tuszynski M.H. Endogenous neurogenesis replaces oligodendrocytes and astrocytes after primate spinal cord injury. J. Neurosci., 2006, Feb 22; 26(8), 2157-2166.
41. Jin K.; Zhu Y.; Sun Y.; Mao X.O.; Xie L.; Greenberg D.A. Vascular endothelial growth factor (VEGF) stimulates neurogenesis in vitro and in vivo. Proc. Natl. Acad. Sci., USA, 2002 Sep. 3; 99(18), 11946-11950. Epub 2002 Aug. 14.
42. Behrstock S.; Ebert A.; McHugh J.; Vosberg S.; Moore J.; Schneider B.; Capowski E.; Hei D.; Kordower J.; Aebischer P.; Svendsen C.N. Human neural progenitors deliver glial cell line-derived neu rotrophic factor to parkinsonian rodents and aged primates. Gene Ther., 2006, Mar; 13(5), 379-388.
43. Park K.I.; Himes B.T.; Stieg P.E.; Tessler A.; Fischer I.; Snyder E.Y. Neural stem cells may be uniquely suited for combined gene therapy and cell replacement: Evidence from engraftment of Neurotrophin-3-expressing stem cells in hypoxic-ischemic brain injury. Exp. Neurol., 2006, May; 199(1), 179-90. Epub 2006 May 22.
44. Martínez-Serrano A.; Björklund A. Ex vivo nerve growth factor gene transfer to the basal forebrain in presymptomatic middle-aged rats prevents the development of cholinergic neuron atrophy and cognitive impairment during aging. Proc. Natl. Acad. Sci. USA. 1998, Feb. 17; 95(4), 1858-1863.
45. Jandial R.; Singec I.; Ames C.P.; Snyder E.Y. Genetic modification of neural stem cells. Mol. Ther., 2008, Mar; 16(3), 450-457. Epub 2008 Feb 5.
46. Kim H.M.; Hwang D.H.; Lee J.E.; Kim S.U.; Kim B.G. Ex vivo VEGF delivery by neural stem cells enhances proliferation of glial progenitors, angiogenesis, and tissue sparing after spinal cord injury. PLoS One. 2009, 4(3), e4987. Epub 2009 Mar 25.
47. Roberson E.D.; Mucke L. 100 years and counting: prospects for defeating Alzheimer's disease. Science, 2006 Nov 3, 314(5800), 781-784.
48. Alloul K.; Sauriol L.; Kennedy W.; Laurier C.; Tessier G.; Novosel S.; Contandriopoulos A. Alzheimer's disease: a review of the disease, its epidemiology and economic impact. Arch. Gerontol. Geriatr. 1998, Nov-Dec, 27(3), 189-221.
49. Benedetti S.; Pirola B.; Pollo B.; Magrassi L.; Bruzzone M.G.; Rigamonti D.; Galli R.; Selleri S.; Di Meco F.; De Fraja C.; Vescovi A.; Cattaneo E.; Finocchiaro G. Gene therapy of experimental brain tumors using neural progenitor cells. Nat. Med., 2000, 6 447-450.
50. Aboody K.S.; Brown A.; Rainov N.G.; Bower K.A.; Liu S.; Yang W.; Small J.E.; Herrlinger U.; Ourednik V.; Black P.M.; Breakefield X.O.; Snyder E.Y. Neural stem cells display extensive tropism for pathology in adult brain: evidence from intracranial gliomas. Proc. Natl. Acad. Sci. USA, 2000, 97, 12846-12851.
51. Ehtesham M.; Kabos P.; Kabosova A.; Neuman T.; Black K.L.; Yu J.S. The use of interleukin 12-secreting neural stem cells for the treatment of intracranial glioma. Cancer Res., 2002, 62, 5657-5663.
52. Ehtesham M.; Kabos P.; Gutierrez M.A.; Chung N.H.; Griffith T.S.; Black K.L.; Yu J.S. Induction of glioblastoma apoptosis using neural stem cell-mediated delivery of tumor necrosis factor-related apoptosis-inducing ligand. Cancer Res., 2002, 62, 7170-7174.
53. Barresi V.; Belluardo N.; Sipione S.; Mudo G.; Cattaneo E.; Condorelli D.F. Transplantation of prodrug-converting neural progenitor cells for brain tumor therapy. Cancer Gene. Ther., 2003, 10, 396-402.
54. Shah K.; Tung C.H.; Breakeeld X.O.; Weissleder R. In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis. Mol. Ther., 2005, 11, 926-931.
55. Kim S.K.; Cargioli T.G.; Machluf M.; Yang W.; Sun Y.; Al-Hashem R.; Kim S.U.; Black P.M.; Carroll R.S. PEX-producing human neural stem cells inhibit tumor growth in a mouse glioma model. Clin. Cancer Res., 2005, 11, 5965-5970.
56. Yuan X.; Hu J.; Belladonna M.L.; Black K.L.; Yu J.S. Interleukin-23-expressing bone marrow-derived neural stem-like cells exhibit antitumor activity against intracranial glioma. Cancer Res., 2006, 66, 2630-2638.
57. Aboody K.S.; Najbauer J.; Schmidt N.O.; Yang W.; Wu J.K.; Zhuge Y.; Przylecki W.; Carroll R.; Black P.M.; Perides G. Targeting of melanoma brain metastases using engineered neural stem/progenitor cells. Neuro. Oncol., 2006, 8, 119-126.
58. Lin D.; Najbauer J.; Salvaterra P.M.; Mamelak A.N.; Barish M.E.; Garcia E.; Metz M.Z.; Kendall S.E.; Bowers M.; Kateb B.; Kim S.U.; Johnson M.; Aboody K.S. Novel method for visualizing and modeling the spatial distribution of neural stem cells within intracranial glioma. Neuroimage, 2007, 37, S18-S26.
59. Li S.; Gao Y.; Tokuyama T.; Yamamoto J.; Yokota N.; Yamamoto S.; Terakawa S.; Kitagawa M.; Namba H. Genetically engineered neural stem cells migrate and suppress glioma cell growth at distant intracranial sites. Cancer Lett., 2007, 251, 220-227.
60. Wu S.; Sasaki A.; Yoshimoto R.; Kawahara Y.; Manabe T.; Kataoka K.; Asashima M.; Yuge L. Neural stem cells improve learning and memory in rats with Alzheimer's disease. Pathobiology, 2008, 75(3), 186-194.
61. Dunnett S.B.; Rosser A.E. Stem cell transplantation for Huntington's disease. Exp. Neurol., 2007, Feb; 203(2), 279-92. Epub 2007 Jan 8.
62. Lin L.F.; Doherty D.; Lile J.; Bektesh S.; Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science, 1993, 260, 1130-1132.
63. Zhu Q.; Ma J.; Yu L.; Yuan C. Grafted neural stem cells migrate to substantia nigra and improve behavior in Parkinsonian rats. Neurosci Lett., 2009, Oct 25; 462(3), 213-218. Epub 2009 Jul 9.
64. Grealish S.; Jönsson M.E.; Li M.; Kirik D.; Björklund A.; Thompson L.H. The A9 dopamine neuron component in grafts of ventral mesencephalon is an important determinant for recovery of motor function in a rat model of Parkinson's disease. Brain, 2010, Feb; 133(Pt 2), 482-495. Epub 2010 Jan 31.
65. Rastegar M.; Hotta A.; Pasceri P.; Makarem M.; Cheung A.Y.; Elliott S.; Park K.J.; Adachi M.; Jones F.S.; Clarke I.D.; Dirks P.; Ellis J. MECP2 isoform-specific vectors with regulated expression for Rett syndrome gene therapy. PLoS One, 2009, Aug 27; 4(8), e6810.
66. Wu W.; Chen X.; Hu C.; Li J.; Yu Z.; Cai W. Transplantation of neural stem cells expressing hypoxia-inducible factor-1alpha (HIF-1alpha) improves behavioral recovery in a rat stroke model. J. Clin. Neurosci., 2010, Jan; 17(1), 92-95. Epub 2009 Nov 12.
67. Shi Y.; Zhou L.; Tian J.; Wang Y. Transplantation of neural stem cells overexpressing glia-derived neurotrophic factor promotes facial nerve regeneration. Acta. Otolaryngol., 2008, Oct. 17, 1-9.
68. Pike-Overzet K.; van der Burg M.;Wagemaker G.; van Dongen J.J.; Staal F.J. New insights and unresolved issues regarding insertional mutagenesis in X-linked SCID gene therapy. Mol. Ther., 2007, 15 1910-1916.
69. Aboody K.S.; Najbauer J.; Danks M.K. Stem and progenitor cellmediated tumor selective gene therapy. Gene Therapy, 2008, 15, 739-752.